Stay updated on Trivalent P2-VP8 Vaccine Clinical Trial
Sign up to get notified when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.

Latest updates to the Trivalent P2-VP8 Vaccine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision (v3.4.2) was added and a government-funding operating-status notice was removed. These changes are cosmetic and do not affect the study details or how the page is used.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding/operating status notice. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a Show glossary option and updated metadata labels to reflect Last Update Submitted that Met QC Criteria and Revision: v3.4.0. The older lowercase variant 'met QC Criteria' and the previous revision tag (v3.3.4) were removed/replaced.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Gauteng as a location under the Locations section. Removed the prior Gauteng Locations entry and the HHS Vulnerability Disclosure link; updated page revision to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Publications section now states entries are automatically filled from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.2. The deletions explain that PubMed-based publications are auto-generated by ClinicalTrials.gov using the NCT number, replacing the prior wording that referenced v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Trivalent P2-VP8 Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trivalent P2-VP8 Vaccine Clinical Trial page.